elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26776380-B600E1B4-2654-4B4F-A2A4-1E74506DBCFF
Q26776380-B600E1B4-2654-4B4F-A2A4-1E74506DBCFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776380-B600E1B4-2654-4B4F-A2A4-1E74506DBCFF
Regenerative medicine: Current therapies and future directions
P2860
Q26776380-B600E1B4-2654-4B4F-A2A4-1E74506DBCFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776380-B600E1B4-2654-4B4F-A2A4-1E74506DBCFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a9dbf273fa8b069df4ca9a2c9cbc99e63131ac42
P2860
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.